|
PhotoThera Stage: Venture Date of Investment: 2006 Web Site : http://www.photothera.com
|
 |
PhotoThera, based in Carlsbad, California, has developed a proprietary,
non-invasive, light-based therapy, called NeuroThera™, for the
treatment of ischemic stroke. Ischemic stroke occurs when a vessel
supplying blood to the brain becomes blocked by a clot or a buildup of
plaque. Estimates show that, in the United States, there are more than
500,000 ischemic strokes annually, and that stroke is the leading cause
of serious long-term disability. In an initial clinical trial, the
NeuroThera device has demonstrated efficacy up to 24 hours after the
onset of stroke. In May 2006, Warburg Pincus participated in a $30.5
million round of Series C venture funding in the company, alongside
Delphi Ventures, DeNovo Ventures, Hamilton BioVentures, The Vertical
Group, and Solstice Capital to fund the Company’s planned U.S. pivotal
clinical trial.
